An urgent need for the discovery of novel anticancer agents is required for the long term therapy of cancer.
Large number of novel bio-active and potential anticancer agents are being used in clinical and pre-clinical trials.
Although many heterocyclic compounds are already available commercially as anticancer agents, great efforts have been
put to identify novel anticancer targets. This review provides an insight of the novel anticancer targets and molecules of
the first and final stage of clinical and pre-clinical trials.
Keywords: Cancer, novel anticancer agents, novel heterocyclic compounds, novel anticancer targets, chemogenomics.
Rights & PermissionsPrintExport